A GLUTATHIONE REDUCTASE-PEG CONJUGATE AND THE USE THEREOF AS AN ANTI-INFLUENZA MEDICAMENT

A Glutathione reductase-PEG conjugate, in which PEG preferably has an average molecular weight ranging from 20,000 to 66,000 daltons, and the use of said conjugate as an anti-influenza medicament are described. Furthermore, the preferred formulae (formulae (I), II) and (III)) of the conjugate of the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MERIZZI, GIULIA FEDERICA, MERIZZI, GIANFRANCO
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A Glutathione reductase-PEG conjugate, in which PEG preferably has an average molecular weight ranging from 20,000 to 66,000 daltons, and the use of said conjugate as an anti-influenza medicament are described. Furthermore, the preferred formulae (formulae (I), II) and (III)) of the conjugate of the invention are illustrated. L'invention porte sur un conjugué glutathion réductase-PEG, dans lequel le PEG a de préférence un poids moléculaire moyen dans une plage de 20 000 à 66 000 daltons, et sur l'utilisation dudit conjugué en tant que médicament anti-grippe. En outre, les formules préférées (formules (I), (II) et (III)) du conjugué de l'invention sont illustrées.